References (Chapter 6)< Back to search results
- Difficulty Introductory
References for “Fair tests of treatments”.
1 Hopkins WA. Patulin in the common cold. IV. Biological properties: extended trial in the common cold. Lancet 1943;ii:631-5.
2 Sanders TAB, Woolfe R, Rantzen E. Controlled evaluation of slimming diets: use of television for recruitment. Lancet 1990;336:918-20.
3 Glasziou P, Chalmers I, Rawlins M, et al. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334: 349-51.
4 Pocock SJ. Randomised clinical trials. BMJ 1977;1:1661.
5 Balfour TG. Quoted in West C (1854). Lectures on the Diseases of Infancy and Childhood. London: Longman, Brown, Green and Longmans, p600.
6 King G, Gakidou E, Imai K, et al. Public policy for the poor? A randomised assessment of the Mexican universal health insurance programme. Lancet 2009;373:1447-54.
7 Peto J, Eden OB, Lilleyman J, et al. Improvement in treatments for children with acute lymphoblastic leukaemia: The Medical Research Council UKALL Trials, 1972-84. Lancet 1986;i:408-11.
8 Noseworthy JH, Ebers GC, Vandervoort MK, et al. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 1994;44:16-20.
9 Moseley JB, O’Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. New England Journal of Medicine 2002;347:81-8.
10 Venning GR. Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms. BMJ 1982;284:249-54.
11 McLernon DJ, Bond CM, Hannaford PC, et al on behalf of the Yellow Card Collaborative. Adverse drug reaction reporting in the UK: a retrospective observational comparison of Yellow Card reports submitted by patients and healthcare professionals. Drug Safety 2010;33:775-88.
12 Kocher T. Ueber Kropfexstirpation und ihre Folgen. Archiv für Klinische Chirurgie 1883;29:254-337.
13 Silverman WA, Andersen DH, Blanc WA, et al. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic regimens. Pediatrics 1956;18:614-25.
14 Zhang J, Ding E, Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 2006;296:1619-21.
15 Vandenbroucke JP, Psaty BM. Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects. JAMA 2008;300:2417-9.
16 Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5.